Effects of umbilical cord serum eye drops in a mouse model of ocular chemical burn

Current Eye Research

Volumn 37, Issue 12, 2012, Pages 1084-1090

  Oh, Han Jin ^a   Jang, Jae Yong ^a   Li, Zhengri ^a   Park, Soo Hyun ^b   Yoon, Kyung Chul ^a  

^a Chonnam National University Medical School   (South Korea)

^b Chonnam National University   (South Korea)

Author keywords

Chemical burn; Corneal haze; Eye drops; Umbilical cord serum; Wound healing

Indexed keywords

EYE DROPS; INTERLEUKIN 1BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMICAL BURN; CORNEA EPITHELIUM; CORNEA INJURY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE EDEMA; HISTOPATHOLOGY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; STROMA; UMBILICAL CORD;

ANIMALS; BURNS, CHEMICAL; CORNEAL DISEASES; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIUM, CORNEAL; EYE BURNS; FETAL BLOOD; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED C57BL; OPHTHALMIC SOLUTIONS; SODIUM HYDROXIDE; WOUND HEALING;

EID: 84870278671     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2012.717243     Document Type: Article

References (34)

1. McCulley JP. Chemical injury of the eye. In: Leibowitz HM, Waring GO. Corneal Disorders. Philiadelphia: W.B. Saunders; 1998. pp 770-790.
2. Wagoner MD. Chemical injuries of the eye: current concepts in pathophysiology and therapy. Surv Ophthalmol 1997;41:275-313. (Pubitemid 27152682)
3. Sharifpour F, Baradaran-Rafi A, Idani E, et al. Oxygen therapy for acute ocular chemical or thermal burns: a pilot study. Am J Ophthalmol 2011;151:823-828.
4. Saika S. Yin and yang in cytokine regulation of corneal wound healing: roles of TNF-alpha. Cornea 2007;26:S70-S74. (Pubitemid 47442766)
5. Poon AC, Geerling G, Dart JK, Fraenkel GE, Daniels JT. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol 2001;85:1188-1197. (Pubitemid 32929543)
6. Matsumoto Y, Dogru M, Goto E, et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 2004;111:1115-1120. (Pubitemid 38736990)
7. Liu L, Hartwig D, Harloff S, et al. An optimised protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol 2005;243:706-714. (Pubitemid 40975497)
8. Vajpayee RB, Mukerji N, Tandon R, et al. Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br J Ophthalmol 2003;87:1312-1316. (Pubitemid 37452549)
9. Yoon KC, Heo H, Jeong IY, et al. Therapeutic effect of umbilical cord serum eyedrops for persistent corneal epithelial defect. Korean J Ophthalmol 2005;19:174-178.
10. Yoon KC, Im SK, Park YG, et al. Application of umbilical cord serum eyedrops for the treatment of dry eye syndrome. Cornea 2006;25:268-272.
11. Yoon KC, Heo H, Im SK, et al. Comparison of autologous serum and umbilical cord serum eye drops for dry eye syndrome. Am J Ophthalmol 2007;144:86-92.
12. Tsubota K, Goto E, Shimmura S, et al. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 1999;106:1984-1989.
13. Tsubota K, Goto E, Fujita H et al. Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol 1999;83:390-395. (Pubitemid 29161176)
14. del Castillo JM, de la Casa JM, Sardiña RC et al. Treatment of recurrent corneal erosions using autologous serum. Cornea 2002;21:781-783.
15. Yoon KC, You IC, Im SK, et al. Application of umbilical cord serum eyedrops for the treatment of neurotrophic keratitis. Ophthalmology 2007;114:1637-1642.
16. Yoon KC, Jeong IY, Im SK, et al. Therapeutic effect of umbilical cord serum eyedrops for the treatment of dry eye associated with graft-versus-host disease. Bone Marrow Transplant 2007;39:231-235.
17. Yoon KC, Choi W, You IC, et al. Application of umbilical cord serum eyedrops for recurrent corneal erosions. Cornea 2011;30:744-748.
18. Salman IA, Gündogdu C. Epithelial healing in experimental corneal alkali wounds with nondiluted autologous serum eye drops. Cutan Ocul Toxicol 2010;29:116-121.
19. Yoon KC, Heo H, Kang IS et al. Effect of topical cyclosporin A on herpetic stromal keratitis in a mouse model. Cornea 2008;27:454-460. (Pubitemid 351591484)
20. Chintakuntlawar AV, Chodosh J. Chemokine CXCL1/KC and its receptor CXCR2 are responsible for neutrophil chemotaxis in adenoviral keratitis. J Interferon Cytokine Res 2009;29:657-666.
21. Brodovsky SC, McCarty CA, Snibson G et al. Management of alkali burns: an 11-year retrospective review. Ophthalmology 2000;107:1829-1835.
22. Foreman DM, Pancholi S, Jarvis-Evans J, et al. A simple organ culture model for assessing the effects of growth factors on corneal re-epithelialization. Exp Eye Res 1996;62:555-564.
23. Becker J, Salla S, Dohmen U, et al. Explorative study of inter-leukin levels in the human cornea. Graefes Arch Clin Exp Ophthalmol 1995;233:766-771.
24. Sotozono C, He J, Matsumoto Y, et al. Cytokine expression in the alkali-burned cornea. Curr Eye Res 1997;16:670-676. (Pubitemid 27322719)
25. Sharma N, Goel M, Velpandian T, et al. Evaluation of umbilical cord serum therapy in acute ocular chemical burns. Invest Ophthalmol Vis Sci 2011;52:1087-1092.
26. Chung JH. Experimental corneal alkali wound healing. Acta Ophthalmol Suppl 1988;187:1-35.
27. Schultz GS, Davis JB, Eiferman RA. Growth factors and cor-neal epithelium. Cornea 1988;7:96-101.
28. Saika S, Kobata S, Hashizume N, et al. Epithelial basement membrane in alkali-burned corneas in rats. Immunohistochemical study. Cornea 1993;12:383-390. (Pubitemid 23249318)
29. Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 2004;88:1467-1474. (Pubitemid 39424732)
30. Higuchi A, Ueno R, Shimmura S, et al. Albumin rescues ocular epithelial cells from cell death in dry eye. Curr Eye Res 2007;32:83-88. (Pubitemid 46328426)
31. Taneri S, Zieske JD, Azar DT. Evolution, techniques, clinical outcomes, and pathophysiology of LASEK: review of the literature. Surv Ophthalmol 2004;49:576-602. (Pubitemid 39505335)
32. Liou LB. Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients. Clin Exp Rheumatol 2001;19:515-523.
33. Ji H, Pettit A, Ohmura K et al. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J Exp Med 2002;196:77-85. (Pubitemid 34747313)
34. Pfugfelder MD. Anti-infammatory therapy for dry eye. Am J Ophthalmol 2004;137:337-342.